Del. Jury Says AngioDynamics Infringes CR Bard Patents
A Delaware federal jury has determined that some of AngioDynamics' implantable port products infringed medical device maker C.R. Bard's patents, with the company saying in a U.S. Securities and Exchange Commission...To view the full article, register now.
Already a subscriber? Click here to view full article